Treatment of Maternal Depression in Home Visitation: Mother and Child Impacts (MIDISII)
|ClinicalTrials.gov Identifier: NCT01212783|
Recruitment Status : Active, not recruiting
First Posted : October 1, 2010
Last Update Posted : July 31, 2017
|Condition or disease||Intervention/treatment||Phase|
|Depressive Disorder in Mothers||Behavioral: In-Home Cognitive Behavioral Therapy Behavioral: Present-Centered Therapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||170 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Treatment of Maternal Depression in Home Visitation: Mother and Child Impacts|
|Study Start Date :||October 2010|
|Actual Primary Completion Date :||May 2017|
|Estimated Study Completion Date :||December 2017|
Active Comparator: Present-Centered Therapy
Mothers will receive 15 weekly sessions of PCT plus two monthly booster sessions following the 15th session.
Behavioral: Present-Centered Therapy
Present-Centered Therapy is a supportive psychotherapy.
Experimental: In-Home Cognitive Behavioral Therapy
Mothers will receive 15 weekly sessions of IH-CBT plus two booster sessions scheduled monthly following the 15th session.
Behavioral: In-Home Cognitive Behavioral Therapy
Adapted form of CBT that is delivered in the home setting, uniquely designed for young, low income new mothers, and is explicitly integrated with home visitation. IH-CBT is delivered by a masters level therapist. It consists of 15 weekly sessions and two monthly booster sessions provided after the 15th session.
- maternal depression [ Time Frame: 23 months ]Maternal depression as measured by self-report, clinician rating based on semi-structured interview, and psychiatric diagnosis based on semi-structured interview.
- child development and social/emotional functioning [ Time Frame: 23 months ]Child developmental status based on standardized developmental assessment, and maternal report of child social/emotional functioning.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01212783
|United States, Ohio|
|Cincinnati Children's Hospital Medical Center|
|Cincinnati, Ohio, United States, 45229|
|Principal Investigator:||Robert T. Ammerman, Ph.D.||Children's Hospital Medical Center, Cincinnati|